MiNK Therapeutics Inc.
(INKT)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -22.46M | -27.99M | -30.21M | -16.24M | -23.80M |
| Depreciation & Amortization | 204.62K | 121.75K | 77.96K | 55.06K | 36.82K |
| Stock-Based Compensation | 3.86M | 3.03M | 1.74M | 87.83K | 219.57K |
| Other Working Capital | 4.81M | 6.11M | 3.89M | -932.79K | 3.23M |
| Other Non-Cash Items | -266.78K | -2.79M | 12.18M | 8.08M | 4.49M |
| Deferred Income Tax | - | - | -355.51K | - | - |
| Change in Working Capital | 2.90M | 8.77M | 3.74M | -324.93K | 4.12M |
| Operating Cash Flow | -15.76M | -18.87M | -12.83M | -8.34M | -14.94M |
| Capital Expenditures | -73.56K | -250.05K | -248.98K | -95.21K | -426.47K |
| Acquisitions | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - |
| Other Investing Acitivies | - | -250.05M | -248.98M | - | - |
| Investing Cash Flow | -73.56K | -250.05K | -248.98K | -95.21K | -426.47K |
| Debt Repayment | - | - | 9.46M | 11.11M | 11.44M |
| Common Stock Repurchased | -477.64K | -157.19K | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 70.47K | 1.59K | 150.00 | - | - |
| Financial Cash Flow | -407.17K | -155.60K | 49.26M | 11.11M | 11.44M |
| Net Cash Flow | -16.27M | -19.25M | 36.20M | 2.39M | -4.06M |
| Free Cash Flow | -15.84M | -19.12M | -13.08M | -8.43M | -15.37M |